ADARX PHARMACEUTICALS, INC.: FY2025 COLLABORATION REV ASSOCIATED WITH ABBVIE AGREEMENT $3.4 MLN, FY2025 NET LOSS $73.1 MLN - SEC FILING

Reuters · 1d ago

Please log in to view news